Engineered EVs—acting on endoplasmic reticulum regulation, ZEB1 and possibly on Wnt/β-catenin and PI3K/AKT pathways—effectively enhanced osteogenesis and neoangiogenesis in diabetic osteopathy [166,167,168]. Here, ZEB1 is linked to diabetes mellitus.